Illumina

Senior Territory Account Manager

Kansas, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Genomics, Life Sciences, Healthcare TechnologyIndustries

Requirements

The candidate must have at least 5 years of life science capital sales experience, with demonstrable experience working with key clinical and research accounts and customers in Kansas and Nebraska. A strong understanding of next-generation sequencing (NGS) and genotyping is foundational, along with knowledge of clinical and research applied genetics and genomics. Proven success in consultative and strategic selling, lead generation, prospecting, business development, and managing complex sales within multi-layered environments is required. The candidate should also possess strong motivation, a drive for results, the ability to work in a fast-paced, adaptable environment, and experience in building long-term customer relationships.

Responsibilities

The Senior Territory Account Manager is responsible for achieving territory sales objectives and growth targets by developing and implementing sales plans, accurately forecasting sales projections, and managing the sales pipeline. This role involves proactively engaging with customers to provide consultations on Illumina's product portfolio, delivering technical and scientific presentations, and identifying new opportunities by monitoring market trends and customer needs. The position requires effective cross-functional collaboration, managing a multi-tiered sales process for capital equipment, consumables, and services, and matching customer business objectives to Illumina's capabilities. Additionally, the role includes prospecting for new leads, actively managing existing accounts, expanding the customer base, and continuously learning about new applications and growth opportunities for Illumina's technology.

Skills

Territory Account Management
Sales Planning
Sales Forecasting
Market Analysis
Competitor Analysis
Genomics
Applied Genetics
Clinical Genomics
Research Genomics
Capital Sales
Consultative Selling
Strategic Selling
Business Development
Lead Generation
Prospecting

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI